Global Smoking Cession Market

Report ID : 1101 | Published : 2021-07-26 | Pages: 140 | Format: PDF/EXCEL

Cigarette smoking is the most significant single cause of illness and premature death globally. Worldwide, tobacco kills 7 million people every year. Almost a million deaths are due to non-smokers being exposed to second-hand smoke. Smoking cessation is the process of ceasing tobacco smoking. It is among one of the dynamic markets and is expected for exponential growth despite the economic conditions. Both prescription and over-the-counter products are available in the market.
The key drivers of the smoking cessation market include increasing tobacco consumption population, awareness amongst smokers on hazards of smoking, banning of tobacco product advertisement in many countries. Strict governmental regulations are emphasized to control the toxic effects on cardiac and respiratory systems. As a step forward, smoking is banned in public places, and high taxes are implemented on tobacco products and massive support to the cessation therapies. The major challenge faced by the market is the side effects of the drugs.


The market of smoking cessation is segmented based on various factors like product type, geography, end-users. Based on cessation aids, it is split by type NRT inhaler, NRT patch, spray, drug electronic cigarettes. Based on end-user, the market is segmented by application pharmacy, supermarket, hospital, other. Based on region, it is segmented as North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, Europe, Middle East & Africa. Due to increased awareness and government programs, APAC can be predicted as a profitable market.
In spite of available OTC and prescribed products, a robust pipeline of drugs is developed by several vendors. Monotherapy products that are already in the market are tested for combination therapy to reach better and rapid therapeutic targets.
Some of the products in the pipeline include X-22 Smoking Cessation Product of 22nd Century Limited is in phase 2; SELA-070, SEL-068 of Selecta Biosciences, Inc., is in phase 1 clinical trials. Despite failed results, unique products such as vaccines are also being investigated by researchers to curb smoking addiction.
Some of the key players include Reckitt Benckiser, Pfizer, GlaxoSmithKline, Roche, Novartis, Johnson and Johnson, Bayer, Cipla, Takeda Pharmaceuticals, Sanofi, Selecta Biosciences, 22nd Century Limited, Fertin Pharma, Achieve Life Sciences, McNeil AB.

  • Reckitt Benckiser
  • Pfizer
  • GlaxoSmithKline
  • Novartis
  • Cipla
  • Takeda
  • Sanofi
  • Selecta Biosciences
  • Fertin Pharma

Global Smoking Cession Market Segmentation

Global Smoking Cession Market Outlook (Revenue, US$ Mn, 2019 – 2030) by Product

  • Smoking Cessation Therapy Products
    • Nicotine Lozenges
    • Nicotine Gums
    • Nicotine Sprays
    • Nicotine Transdermal Patches
  • Drug Therapy
    • Zyban (Bupropion)
    • Chantix (varenicline)
  • Nicotine Sublingual Tablets
  • Nicotine Inhalers
  • E-cigarettes

Global Smoking Cession Market Outlook (Revenue, US$ Mn, 2019 – 2030) by End-user

  • Application pharmacy
  • Supermarket
  • Hospital

Global Smoking Cession Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Region

  • North America
    • S.
    • Canada
  • Europe
    • K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients